Saturday, October 3, 2026

USD/CNH Is 3% Down In The Last 21 Sessions

ViaNews Editorial Team

February 21, 2023

USD/CNH Is 3% Down In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 3.92% for the last 21 sessions. At 16:12 EST on Tuesday, 21 February, USD/CNH (USDCNH) is $6.89.

USD/CNH's yearly highs and lows, it's 0.531% up from its 52-week low and 0.057% down from its 52-week high.

News about

  • Eur/usd aims to recapture 1.0700 as risk appetite recovers, fed minutes in focus. According to FXStreet on Monday, 20 February, "The EUR/USD pair has attempted a recovery after dropping to near 1.0673 in the early European session. "
  • Eur/usd: hawkish set of FOMC minutes required to see a break towards 1.05 – ING. According to FXStreet on Monday, 20 February, "The Dollar rally might have come far enough for the time being and EUR/USD found good demand ahead of 1.06. ", "It will probably require quite a hawkish set of FOMC minutes on Wednesday for EUR/USD to break towards 1.05 - where we expect to see good demand ahead of a EUR/USD rally in the second quarter."
  • Eur/usd price analysis: bears approach 11-week-old support line near 1.0620. According to FXStreet on Tuesday, 21 February, "Following that, a three-week-long horizontal resistance area near 1.0800-05 could act as the last defense of the EUR/USD bears.", "In a case where the EUR/USD pair remains firmer past 1.0805, the odds of witnessing a run-up towards the 1.1000 psychological magnet and then to the monthly high near 1.1035 can't be ruled out."
  • Eur/usd: hawkish ECB talks, upbeat EU data tease bulls near 1.0700, pmis in focus. According to FXStreet on Monday, 20 February, "Against this backdrop, Wall Street was closed and US Treasury yields eased, which in turn weighed on the US Dollar Index (DXY) and allowed the EUR/USD to remain firmer, defending Friday's rebound from the six-week low.", "Moving on, the return of full markets may highlight the geopolitical fears surrounding the US-China tussles over Taiwan and balloon shooting, not to forget the North Korean missile firing, to weigh on the sentiment and the EUR/USD prices."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com